Expert Pitch

'Xenophobic' immigration order is likely unconstitutional

Cornell University
21-Apr-2020 11:10 AM EDT, by Cornell University

On Monday, President Trump said in a tweet that he would sign an executive order temporarily suspending immigration to the United States in the midst of the coronavirus outbreak. The executive order is anticipated to include halting new green cards and work visas.

Stephen Yale-Loehr, professor of immigration law at Cornell Law School, is an expert on immigration and asylum law in the United States. He says that the executive order will almost certainly face legal challenges. 

Bio: https://www.lawschool.cornell.edu/faculty/bio_stephen_yale-loehr.cfm

Yale-Loehr says: 

“An executive order suspending all immigration into the United States is outrageous and likely unconstitutional. It is one thing to suspend immigration for certain categories of people such as terrorists. It is quite another to suspend all immigration. We have never done that before, even during world wars. Litigation is sure to challenge any such executive order.”

 

Ian Kysel, visiting assistant clinical professor of law at Cornell Law School, is co-founder and director of the International Migrants Bill of Rights Initiative and says that the proposed executive order would violate basic international human rights law.

Bio: https://www.lawschool.cornell.edu/faculty/bio.cfm?id=1025

Kysel says:

“President Trump has announced (without any detail) that he will unilaterally seek to end immigration to the U.S. to fight the ‘invisible enemy’ (presumably COVID-19) – an action that, if attempted, would have devastating consequences for families, universities, businesses and communities around the country. 

“Even more than doubling-down on an apparently xenophobic effort to dismantle the U.S. immigration system, a blanket ban unmoored from public health imperatives violates basic international human rights law obligations. Binding treaties the U.S. helped draft prohibit such indiscriminate acts of political theater, including because they prevent refugees from receiving sanctuary and tear families apart.”

 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.15484